对Rebholz S.L.等人所著《食用含全氟辛酸的西方饮食导致的高胆固醇血症取决于小鼠的品系和性别》的评论，《毒理学报告》2016年（第3期）46 - 54页 - Suppr

Suppr

超能文献

Comment on "Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice" by Rebholz S.L. et al. Toxicol. Rep. 2016 (3) 46-54.

作者信息

Princen Hans M G, Pouwer Marianne G, Pieterman Elsbet J

机构信息

TNO-Metabolic Health Research, Gaubius Laboratory, Leiden, The Netherlands.

出版信息

Toxicol Rep. 2016 Feb 11;3:306-309. doi: 10.1016/j.toxrep.2016.02.002. eCollection 2016.

DOI:10.1016/j.toxrep.2016.02.002

PMID:28959551

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5615825/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c190/5615825/6345a2e0704c/gr1.jpg

相似文献

Comment on "Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice" by Rebholz S.L. et al. Toxicol. Rep. 2016 (3) 46-54.

Toxicol Rep. 2016 Feb 11;3:306-309. doi: 10.1016/j.toxrep.2016.02.002. eCollection 2016.

Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice.

Toxicol Sci. 2019 Apr 1;168(2):519-534. doi: 10.1093/toxsci/kfz015.

Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice.

Toxicol Rep. 2016;3:46-54. doi: 10.1016/j.toxrep.2015.11.004.

Phenotype interaction of apobec-1 and CETP, LDLR, and apoE gene expression in mice: role of apoB mRNA editing in lipoprotein phenotype expression.

Arterioscler Thromb Vasc Biol. 1998 May;18(5):747-55. doi: 10.1161/01.atv.18.5.747.

Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice.

Atherosclerosis. 2008 Mar;197(1):57-63. doi: 10.1016/j.atherosclerosis.2007.08.001. Epub 2007 Sep 14.

Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.

Arterioscler Thromb Vasc Biol. 2006 Nov;26(11):2552-9. doi: 10.1161/01.ATV.0000243925.65265.3c. Epub 2006 Aug 31.

Overexpression of apolipoprotein E in transgenic mice: marked reduction in plasma lipoproteins except high density lipoprotein and resistance against diet-induced hypercholesterolemia.

Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1750-4. doi: 10.1073/pnas.89.5.1750.

Relation between cholesterol ester transfer protein activities and lipoprotein cholesterol in patients with hypercholesterolemia and combined hyperlipidemia.

Arterioscler Thromb Vasc Biol. 1995 Jan;15(1):112-20. doi: 10.1161/01.atv.15.1.112.

Taq1B CETP polymorphism, plasma CETP, lipoproteins, apolipoproteins and sex differences in a Jewish population sample characterized by low HDL-cholesterol.

Atherosclerosis. 2000 Aug;151(2):509-18. doi: 10.1016/s0021-9150(99)00408-6.

PXR agonism decreases plasma HDL levels in ApoE3-Leiden.CETP mice.

Biochim Biophys Acta. 2009 Mar;1791(3):191-7. doi: 10.1016/j.bbalip.2008.12.008. Epub 2008 Dec 25.

引用本文的文献

Effects of life-long hyperlipidaemia on age-dependent development of endothelial dysfunction in humanised dyslipidaemic mice.

Geroscience. 2025 Apr 17. doi: 10.1007/s11357-025-01578-w.

Diet as an Exposure Source and Mediator of Per- and Polyfluoroalkyl Substance (PFAS) Toxicity.

Front Toxicol. 2020 Dec 4;2:601149. doi: 10.3389/ftox.2020.601149. eCollection 2020.

Exposure to a mixture of legacy, alternative, and replacement per- and polyfluoroalkyl substances (PFAS) results in sex-dependent modulation of cholesterol metabolism and liver injury.

Environ Int. 2021 Dec;157:106843. doi: 10.1016/j.envint.2021.106843. Epub 2021 Aug 31.

Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and men.

Sci Rep. 2021 Mar 3;11(1):5050. doi: 10.1038/s41598-021-83974-8.

In Vivo Magnetic Resonance Imaging-Based Detection of Heterogeneous Endothelial Response in Thoracic and Abdominal Aorta to Short-Term High-Fat Diet Ascribed to Differences in Perivascular Adipose Tissue in Mice.

J Am Heart Assoc. 2020 Nov 3;9(21):e016929. doi: 10.1161/JAHA.120.016929. Epub 2020 Oct 19.

Alirocumab, evinacumab, and atorvastatin triple therapy regresses plaque lesions and improves lesion composition in mice.

J Lipid Res. 2020 Mar;61(3):365-375. doi: 10.1194/jlr.RA119000419. Epub 2019 Dec 16.

Anti-PCSK9 antibodies inhibit pro-atherogenic mechanisms in APOE*3Leiden.CETP mice.

Sci Rep. 2019 Jul 31;9(1):11079. doi: 10.1038/s41598-019-47242-0.

The APOE3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis.

J Diabetes Res. 2019 Feb 21;2019:9727952. doi: 10.1155/2019/9727952. eCollection 2019.

Dose Effects of Ammonium Perfluorooctanoate on Lipoprotein Metabolism in APOE*3-Leiden.CETP Mice.

Toxicol Sci. 2019 Apr 1;168(2):519-534. doi: 10.1093/toxsci/kfz015.

Stochastic Pharmacokinetic-Pharmacodynamic Modeling for Assessing the Systemic Health Risk of Perfluorooctanoate (PFOA).

Toxicol Sci. 2018 May 1;163(1):293-306. doi: 10.1093/toxsci/kfy035.

本文引用的文献

Hypercholesterolemia with consumption of PFOA-laced Western diets is dependent on strain and sex of mice.

Toxicol Rep. 2016;3:46-54. doi: 10.1016/j.toxrep.2015.11.004.

Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising: A systematic review and meta-analysis of relevant preclinical studies and clinical trials.

Eur J Pharmacol. 2015 Sep 15;763(Pt A):48-63. doi: 10.1016/j.ejphar.2015.03.089. Epub 2015 May 16.

PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE.

J Lipid Res. 2014 Nov;55(11):2370-9. doi: 10.1194/jlr.M053207. Epub 2014 Sep 25.

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin.

J Lipid Res. 2014 Oct;55(10):2103-12. doi: 10.1194/jlr.M051326. Epub 2014 Aug 19.

LDL cholesterol: controversies and future therapeutic directions.

Lancet. 2014 Aug 16;384(9943):607-617. doi: 10.1016/S0140-6736(14)61009-6.

HDL-targeted therapies: progress, failures and future.

Nat Rev Drug Discov. 2014 Jun;13(6):445-64. doi: 10.1038/nrd4279. Epub 2014 May 23.

APOE*3Leiden.CETP transgenic mice as model for pharmaceutical treatment of the metabolic syndrome.

Diabetes Obes Metab. 2014 Jun;16(6):537-44. doi: 10.1111/dom.12252. Epub 2014 Jan 16.

Niacin Reduces Atherosclerosis Development in APOE*3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol.

PLoS One. 2013 Jun 19;8(6):e66467. doi: 10.1371/journal.pone.0066467. Print 2013.

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.

Lancet. 2010 Nov 13;376(9753):1670-81. doi: 10.1016/S0140-6736(10)61350-5. Epub 2010 Nov 8.

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors.

Eur Heart J. 2010 Jan;31(2):149-64. doi: 10.1093/eurheartj/ehp399. Epub 2009 Oct 12.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验